163 related articles for article (PubMed ID: 23760614)
1. Utility of peripheral blood for cytogenetic and mutation analysis in myelodysplastic syndrome.
Mohamedali AM; Alkhatabi H; Kulasekararaj A; Shinde S; Mian S; Malik F; Smith AE; Gäken J; Mufti GJ
Blood; 2013 Jul; 122(4):567-70. PubMed ID: 23760614
[TBL] [Abstract][Full Text] [Related]
2. High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS).
Mohamedali AM; Gäken J; Ahmed M; Malik F; Smith AE; Best S; Mian S; Gaymes T; Ireland R; Kulasekararaj AG; Mufti GJ
Leukemia; 2015 Sep; 29(9):1928-38. PubMed ID: 25943179
[TBL] [Abstract][Full Text] [Related]
3. Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?
Cherry AM; Slovak ML; Campbell LJ; Chun K; Eclache V; Haase D; Haferlach C; Hildebrandt B; Iqbal AM; Jhanwar SC; Ohyashiki K; Sole F; Vandenberghe P; VanDyke DL; Zhang Y; Dewald GW
Leuk Res; 2012 Jul; 36(7):832-40. PubMed ID: 22537394
[TBL] [Abstract][Full Text] [Related]
4. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing.
Arenillas L; Mallo M; Ramos F; Guinta K; Barragán E; Lumbreras E; Larráyoz MJ; De Paz R; Tormo M; Abáigar M; Pedro C; Cervera J; Such E; José Calasanz M; Díez-Campelo M; Sanz GF; Hernández JM; Luño E; Saumell S; Maciejewski J; Florensa L; Solé F
Genes Chromosomes Cancer; 2013 Dec; 52(12):1167-77. PubMed ID: 24123380
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the utility of peripheral blood vs bone marrow in karyotype and fluorescence in situ hybridization for myelodysplastic syndrome diagnosis.
Asadi Fakhr Z; Mehrzad V; Izaditabar A; Salehi M
J Clin Lab Anal; 2018 Nov; 32(9):e22586. PubMed ID: 29893006
[TBL] [Abstract][Full Text] [Related]
7. Multiplex ligation-dependent probe amplification assay identifies additional copy number changes compared with R-band karyotype and provide more accuracy prognostic information in myelodysplastic syndromes.
Wang J; Ai X; Qin T; Xu Z; Zhang Y; Liu J; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Cai W; Ru K; Jia Y; Huang G; Xiao Z
Oncotarget; 2017 Jan; 8(1):1603-1612. PubMed ID: 27906673
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and prognosis in myelodysplastic syndromes. The impact of cytogenetics].
Mecucci C
Recenti Prog Med; 2014 Mar; 105(3):110-4. PubMed ID: 24675452
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic potential of morphological and cytogenetic indices in patients with myelodysplastic syndrome].
Gritsaev SV; Martynkevich IS; Abdulkadyrov KM; Tiranova SA; Kakaĭ MP; Martynenko LS; Dziavgo LA
Ter Arkh; 2005; 77(7):22-7. PubMed ID: 16116904
[TBL] [Abstract][Full Text] [Related]
11. Cytogenomic array detects a subset of myelodysplastic syndrome with increased risk that is invisible to conventional karyotype.
Choi SM; Van Norman SB; Bixby DL; Shao L
Genes Chromosomes Cancer; 2019 Nov; 58(11):756-774. PubMed ID: 31334569
[TBL] [Abstract][Full Text] [Related]
12. Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity.
Steensma DP; List AF
Mayo Clin Proc; 2005 May; 80(5):681-98. PubMed ID: 15887439
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes.
Duong VH; Padron E; Al Ali NH; Lancet JE; Hall J; Kwok B; Zhang L; Epling-Burnette PK; List AF; Komrokji RS
Ann Hematol; 2018 Feb; 97(2):247-254. PubMed ID: 29167940
[TBL] [Abstract][Full Text] [Related]
14. Using peripheral blood circulating DNAs to detect CpG global methylation status and genetic mutations in patients with myelodysplastic syndrome.
Iriyama C; Tomita A; Hoshino H; Adachi-Shirahata M; Furukawa-Hibi Y; Yamada K; Kiyoi H; Naoe T
Biochem Biophys Res Commun; 2012 Mar; 419(4):662-9. PubMed ID: 22382018
[TBL] [Abstract][Full Text] [Related]
15. Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes.
Wall M
Methods Mol Biol; 2017; 1541():209-222. PubMed ID: 27910026
[TBL] [Abstract][Full Text] [Related]
16. Updates in cytogenetics and molecular markers in MDS.
Tiu RV; Visconte V; Traina F; Schwandt A; Maciejewski JP
Curr Hematol Malig Rep; 2011 Jun; 6(2):126-35. PubMed ID: 21340513
[TBL] [Abstract][Full Text] [Related]
17. Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization: Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes.
He R; Wiktor AE; Durnick DK; Kurtin PJ; Van Dyke DL; Tefferi A; Patnaik MS; Ketterling RP; Hanson CA
Am J Clin Pathol; 2016 Jul; 146(1):86-94. PubMed ID: 27353768
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.
Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ
Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood cell-free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes.
Suzuki Y; Tomita A; Nakamura F; Iriyama C; Shirahata-Adachi M; Shimada K; Akashi A; Ishikawa Y; Kaneda N; Kiyoi H
Cancer Sci; 2016 Sep; 107(9):1329-37. PubMed ID: 27323954
[TBL] [Abstract][Full Text] [Related]
20. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
